Autopsy report · NCT06313632

Erector Spinae Plane Block With Bupivacaine for Medical Thoracoscopy

“interim, lack of obvious benefit”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year before it stopped.
• 33 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Icahn School of Medicine at Mount Sinai

Sponsor type

University, hospital or other

Conditions

Pleural Disease; Postoperative Pain

Interventions

Bupivacaine injection; Placebo; Monitored Anesthesia Care

Participants

33

Sites

1

Countries

United States

Trials that died the same way

• ICVT in HPV-induced Genital Lesions of Immunocompromised and Immunocompetent Patients
  “Lack of effect in interim analysis” (70% match in meaning)
• The Role of Post-traumatic Inhibition of the Innate and Adaptive Immune System in the Development of Infectious Complications in Severely Injured Patients
  “Interim analysis provided enough data” (60% match in meaning)
• Liberty Analyzer WBC System: Reference Interval Study
  “For interim analysis.” (59% match in meaning)
• A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression
  “Interim assessment: Lack of efficacy” (58% match in meaning)
• King Video Laryngoscope Versus Direct Laryngoscopy for Prehospital Intubation: A Randomized Controlled Trial
  “Interim analysis suggested additional enrollment would not change outcomes” (58% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.